Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0001104659-22-129121

10% owner bought 98,787 shares at $5.90 ($582,814)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
RA CAPITAL MANAGEMENT, L.P. 10% owner 2022-12-19 Purchase +98,787 $5.90 $582,814 9,501,836 I
Open-market purchases · 98,787 sh · avg $5.90 · $582,814
Loading xslF345X03/tm2233247-1_4.xml…